Clinical trial

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

NCT07420439

Study summary

ClinicalTrials.gov

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

8 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Paclitaxel Normalized identity: paclitaxel View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Bevacizumab Normalized identity: bevacizumab View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Carboplatin Normalized identity: carboplatin View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pemetrexed Normalized identity: pemetrexed View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Vinorelbine Normalized identity: vinorelbine View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Nivolumab Normalized identity: nivolumab View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pembrolizumab Normalized identity: pembrolizumab View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Gemcitabine Normalized identity: gemcitabine View linked drug · Find medicine records · Find other trials using this name

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-09-15

PhasePHASE2

Conditions

Non Small Cell Lung Cancer Metastaticunresolved

Interstitial Lung Disease (ILD)unresolved

Interventions

PaclitaxelDRUG · verified · RxNorm: paclitaxel

BevacizumabDRUG · verified · RxNorm: bevacizumab

CarboplatinDRUG · verified · RxNorm: carboplatin

PemetrexedDRUG · verified · RxNorm: pemetrexed

VinorelbineDRUG · verified · RxNorm: vinorelbine

NivolumabDRUG · verified · RxNorm: nivolumab

PembrolizumabDRUG · verified · RxNorm: pembrolizumab

GemcitabineDRUG · verified · RxNorm: gemcitabine

Sponsors & collaborators

Intergroupe Francophone de Cancerologie Thoraciquelead sponsor

Mapped research locations

ParisFrance5 MarseilleFrance2 MontpellierFrance1 LyonFrance1 StrasbourgFrance1 LilleFrance1 NantesFrance1 RennesFrance1 DijonFrance1 CaenFrance1 Clermont-FerrandFrance1 GrenobleFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07420439 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.